Former FDA chief discusses vaccine timeline: This will be a staged authorization approval

Moderna’s stock is down today after CEO Stephanie Bancel told CNBC the company plans to slow its enrollment of its clinical vaccine trial to ensure it has sufficient representation of minorities at risk for the disease. Two-thirds of people enrolled are white while 20 percent are Hispanic and 7 percent Black, according to Moderna’s data. Dr. Scott Gottlieb, former FDA Commissioner, joins ‘Closing Bell’ to discuss. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

For info on the best credit cards go to CNBC Select:
https://www.cnbc.com/select/best-credit-cards/

#CNBC
#CNBCTV

Видео Former FDA chief discusses vaccine timeline: This will be a staged authorization approval канала CNBC Television